Table 1 Clinical features of 45 reported pancreatic giant insulinomas
From: Giant insulinoma: report of a case and review of published reports
Variables | |
Age (mean) | 15–83 (57) years |
Sex (M:F) | 1.14:1 |
Tumor diameter (mean) | 9–21 (12) cm |
Location | |
H/HB/B/BT/T/HBT/NA | 3/1/2/13/22/1/3 |
Treatment for primary disease | |
DP (+/− S)/DP+ RLM/DP+ ALM | 23/2/2 |
PD/TP/E/TR/biopsy/NO/NA | 3/1/1/4/3/5/1 |
Metastatic sites | |
Generalized/liver/LN, surround | 6/7/12 |
Recurrences/remnant/none | 8/11/26 |
Recurrent sites | |
Generalized/liver/local | 2/4/1 |
Treatment of recurrences or remnant | |
Surgery/Syst chemo/HACE/RT/none/NA | 3/2/2/2/1/7 |
Outcome (n) | Duration of follow-up (mean) months |
No disease recurrence (24) | 3–276 (18) |
Alive with disease (6) | 15–204 (48) |
Died of metastatic disease (10) | 1–156 (24) |
Died of other disease (1) | NA |
NA (4) | NA |